期刊文献+

血清和肽素水平与心力衰竭程度及左室重构的相关性分析 被引量:11

暂未订购
导出
摘要 目的测定心力衰竭患者血清和肽素水平,探讨其与心力衰竭及心室重构程度的相关性。方法入选60例心力衰竭患者,其中缺血性心肌病(ICM)23例,扩张型心肌病(DCM)18例,高血压性心脏病(HHD)19例。依照NYHA分级分为两组,心功能Ⅲ级、Ⅳ级亚组各30例。另设健康对照组30名。测定所有入选者血清和肽素水平。结果心力衰竭组血清和肽素水平比健康对照组明显升高,且随心力衰竭程度的加重而增加;ICM组和肽素水平高于DCM组(P<0.05);和肽素水平与左室舒张末期内径(LVDd)呈正相关(β=0.372,P<0.001),和肽素水平与左室射血分数(LVEF)呈独立负相关(β=-0.388,P<0.001)。结论和肽素水平作为一个新的心力衰竭标志物,可以评估心力衰竭程度、判断心力衰竭预后,同时和肽素与左心室大小及心室重构相关,干预血管加压素(AVP)系统可能会有助于心力衰竭的治疗。
出处 《中西医结合心脑血管病杂志》 2012年第7期792-793,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献11

  • 1Katan M, Morgenthaler NG, Dixit KC, et al. Anterior and pos- terior pituitary function testing with simultaneous in sulin toler- ance test and a novel copeptin assay[J]. J Clin Endocrinol Metab, 2007,92:2640 - 2643.
  • 2Cowley AW, Merrill D, Osborn J, et al. Influence of vasopressin and angiotensin on baroreflexes in the dog[J]. Circ Res, 1984,54: 163 - 172.
  • 3奚卉,周文,于红玖.和肽素在心血管疾病中的研究进展[J].大连医科大学学报,2010,32(3):359-362. 被引量:8
  • 4Goldsmith SR. Vasopressin as vasopressor[J]. Am J Med, 1987, 82.-1213 - 1219.
  • 5Fukuzawa J, Haneda T, Kikuchi K. Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor[J]. Mol Cell Biochem,1999,195:93 - 98.
  • 6Fan YH, Zhao LY, Zheng QS, et al. Arginine vasopressin increases iNOS- NO system activity in cardiac fihroblasts through NF - kappa B activation and its relation with myocardial fibrosis[J]. Life Sci,2007,81:327 - 335.
  • 7Gheorghiade M, Konstam MA, Burnett JC, et al. Shortterm clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hos pitalized for heart failure: The EVEREST Clinical Status Trials [J]. JAMA,2007,297:1332 - 1343.
  • 8Wada K, Fujimori A, Matsukawa U. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction - induced congestive heart failure[J]. Eur J Pharmaco,2005,507:145 - 151.
  • 9Gegenhuber A, Struck J, Dieplinger B, et al. Comparative evalua- tion of B - type natriuretic peptide, mid - regional pro - A - type natriuretic peptide, mid- regional pro- adrenomedullin, and copep- tin to predict 1 - year mortality in patients with acute destabilized heart failure[J]. Card Fail, 2007,13 : 42 - 49.
  • 10叶忠,郑兴.冠心病患者血浆和肽素水平的测定及其对冠脉病变程度的诊断价值[J].第二军医大学学报,2009,30(10):1154-1157. 被引量:5

二级参考文献34

  • 1马丽萍,秦永文,郑兴,吴弘,丁继军,赵仙先,郭品娥.高敏感C反应蛋白和淀粉样物质A与冠状动脉病变程度的关系[J].第二军医大学学报,2004,25(7):763-765. 被引量:4
  • 2Katan M,Morgenthaler N G,Dixit K C,Rutishauser J,Brabant G E,Muller B, et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay[J]. J Clin Endocrinol Metab, 2007, 92: 2640- 2643.
  • 3Szinnai G, Morgenthaler N G, Berneis K, Struck J, Mailer B, Keller U,et al. Changes in plasma copeptin,the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects[J]. J Clin Endocrinol Metab,2007,92: 3973-3978.
  • 4Tolg R, Witt M, Schwarz B, Kurz T, Kurowski V, Hartmann F,et al. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention-the PASSAT Study[J]. Clin Res Cardiol, 2006, 95:31-41.
  • 5Khan S Q,Dhillon O S,O'Brien R J,Struck J,Quinn P A,Morgenthaler N G,et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study [J]. Circulation, 2007,115:2103-2110.
  • 6Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983,51:606.
  • 7Babar S I,Berg R A, Hilwig R W,Kern K B,Ewy G A. Vasopressin versus epinephrine during cardiopulmonary resuscitation: a randomized swine outcome study[J]. Resuscitation, 1999,41:185-192.
  • 8Voelckel W G, Lurie K G, McKnite S, Zielinski T, Lindstrom P,Peterson C,et al. Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation[J]. Crit Care Med, 2002,30 : 957-962.
  • 9Wenzel V,Lindner K H,Mayer H,Lurie K G,Prengel A W. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs[J]. Resuscitation, 1998,38 : 13-17.
  • 10Cowley A W Jr, Merrill D, Osborn J, Barber B J. Influence of vasopressin and angiotensin on baroreflexes in the dog[J]. Circ Res,1984,54:163-172.

共引文献11

同被引文献106

  • 1李佐民.永久性心房纤颤伴长RR间期行单腔起搏器植入患者调低起搏下限频率对血浆脑钠肽水平的影响[J].黑龙江医药,2012,25(5):688-689. 被引量:2
  • 2王蓉.进行血NT-proBNP及尿酸联合检测在诊断老年慢性心力衰竭方面的临床价值分析[J].当代医药论丛,2014,12(6):59-60. 被引量:8
  • 3毛姗姗,叶菁菁,蒋国平,赵正言.定量组织速度成像和组织追踪显像技术评价先天性甲状腺功能减退症新生儿的右心功能[J].中华儿科杂志,2007,45(8):599-603. 被引量:9
  • 4Morgenthaler NG;Struck J;Bergm ann A.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin,2006(01).
  • 5Wayne L. Miller,Karen A. Hartman,David O. Hodge,Stacy Hartman,Joachim Struck,Nils G. Morgenthaler,Andreas Bergmann,Allan S. Jaffe.Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm[J]Journal of Cardiovascular Translational Research,2009(4).
  • 6Alfons Gegenhuber,Joachim Struck,Benjamin Dieplinger,Werner Poelz,Richard Pacher,Nils G. Morgenthaler,Andreas Bergmann,Meinhard Haltmayer,Thomas Mueller.Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure[J]Journal of Cardiac Failure,2007(1).
  • 7Voors AA,von Haehling S,Anker SD,et al.C-terminal provasopressin (copeptin)is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL studyEuropean Heart Journal,2009.
  • 8Tentzeris I,Jari R,Farhan S,et al.Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic hearts failureThe Journal of Clinical Endocrinology,2011.
  • 9Alehagen U,Dahlstrom U,Rehfeld J F,et al.Association of copeptin and N-terminal proBNP concentrations with risk of cardiocvascular death in older patients with symptoms of heart failureThe Journal of The American Medical Association,2011.
  • 10Dieplinger B,Gegenhuber A,Haltmayer M,et al.Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in patients with shortness of breathHeart,2009.

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部